ScopeKlinikum der Universität Augsburg (Universitätsklinikum Augsburg) Institut für Humangenetik
31 capabilities
Accredited since May 2026
Verified Sep 2026
One of 3,103 in Germany
Send one structured enquiry and we chase the reply for you. No cold email, no chasing.
Details
Stenglinstraße 2
Augsburg 86156 , Germany
Augsburg 86156 , Germany
Accreditation
Active
DAkkS
D-ML-13136-01-01
Performs molecular genetic diagnostic testing in human genetics, including analysis of hereditary conditions such as familial breast and ovarian cancer genes, using DNA extracted from blood and tissue samples.
Accreditation Details
Accreditation Body
DAkkS
Number
D-ML-13136-01-01
Status
ActiveSince
04 May 2026
Accreditation is granted under EU Regulation 765/2008 and assessed against ISO/IEC 17025. Data sourced from official DAkkS records.
Download Scope PDFAdditional scope documents
Test Capabilities (31)
| Standard Reference | Description | Category |
|---|---|---|
| (DICER1 ); SNV, CNV | (DICER1 ); SNV, CNV | Molecular Diagnostics / PCR |
| (PDGFRB, NOTCH3 ); SNV, CNV | (PDGFRB, NOTCH3 ); SNV, CNV | Molecular Diagnostics / PCR |
| 1/4 (DKN1B, MEN1 ); SNV, CNV | 1/4 (DKN1B, MEN1 ); SNV, CNV | Molecular Diagnostics / PCR |
| Aicardi-Goutières-Syndrom (ADAR, IFIH1, RNASEH2A, RNASEH2B, RNASEH2C, SAMHD1, TREX1 ); SNV, CNV | Aicardi-Goutières-Syndrom (ADAR, IFIH1, RNASEH2A, RNASEH2B, RNASEH2C, SAMHD1, TREX1 ); SNV, CNV | Molecular Diagnostics / PCR |
| Brust- und Eierstockkrebs | Familiärer Brust- und Eierstockkrebs | Molecular Diagnostics / PCR |
| CNV | [OMIM*601623]; SNV, CNV | Molecular Diagnostics / PCR |
| DICER1-assozierte Tumordisposition | DICER1-assozierte Tumordisposition | Molecular Diagnostics / PCR |
| Darmkrebs, adenomatöse Polyposis | Darmkrebs, adenomatöse Polyposis | Molecular Diagnostics / PCR |
| Endometriumkarzinom (FH, MLH1, MSH2, MSH6, PMS2, PTEN, EPCAM, MUTYH, NTHL1, POLD1, POLE, SMAD4 ); SNV, CNV | Endometriumkarzinom (FH, MLH1, MSH2, MSH6, PMS2, PTEN, EPCAM, MUTYH, NTHL1, POLD1, POLE, SMAD4 ); SNV, CNV | Molecular Diagnostics / PCR |
| Infantile Myofibromatose | Infantile Myofibromatose | Molecular Diagnostics / PCR |
| MSH2, MSH6, MUTYH, PMS2, PTEN, RAD51C, RAD51D, STK11, TP53 | MSH2, MSH6, MUTYH, PMS2, PTEN, RAD51C, RAD51D, STK11, TP53 | Molecular Diagnostics / PCR |
| MSH2, MSH6, NBN, PALB2, PTEN, RAD51C, RAD51D, STK11, TP53 | MSH2, MSH6, NBN, PALB2, PTEN, RAD51C, RAD51D, STK11, TP53 | Molecular Diagnostics / PCR |
| Multiple Endokrine Neoplasie Typ | Multiple endokrine Neoplasie Typ | Molecular Diagnostics / PCR |
| Paragangliom, Phäochromozytom | Paragangliom, Phäochromozytom | Molecular Diagnostics / PCR |
| Rhythmusstörungen (ABCC9, AKAP9, ANK2,TTN); SNV, CNV | Rhythmusstörungen (ABCC9, AKAP9, ANK2,TTN); SNV, CNV | Molecular Diagnostics / PCR |
| Syndrom (PTEN ); SNV, CNV | Syndrom (PTEN ); SNV, CNV | Molecular Diagnostics / PCR |
| TP53 ); SNV, CNV | Tumorprädisposition (AKT1, APC, ATM,TP53); SNV, CNV | Molecular Diagnostics / PCR |
| (TruSight Oncology 500 v2) (RET | (TruSight Oncology 500 v2) (RET | Other |
| Birt-Hogg-Dubé-Syndrom (FLCN | Birt-Hogg-Dubé-Syndrom (FLCN | Other |
| Foundervariante); SNV, CNV | Foundervariante); SNV, CNV | Other |
| MSH2, MSH6, EPCAM ); SNV, CNV | MSH2, MSH6, EPCAM ); SNV, CNV | Other |
| Noonan-Syndrom Basis (PTPN11 | Noonan-Syndrom Basis (PTPN11 | Other |
| POLE ); SNV, CNV | POLE ); SNV, CNV | Other |
| PTCH1 ); SNV, CNV | PTCH1 ); SNV, CNV | Other |
| Pankreaskarzinom, familiäres (APC | Pankreaskarzinom, familiäres (APC | Other |
| Peutz-Jeghers-Syndrom (STK11 | Peutz-Jeghers-Syndrom (STK11 | Other |
| RAD51D, HOXB13- | RAD51D, HOXB13- | Other |
| SMARCB1 ); SNV, CNV | SMARCB1 ); SNV, CNV | Other |
| Tuberöse Sklerose (TSC1, TSC2 | Tuberöse Sklerose (TSC1, TSC2 | Other |
| VHL, BAP1, TSC1, TSC2 ); SNV, CNV | VHL, BAP1, TSC1, TSC2 ); SNV, CNV | Other |
| bearbeitet und analysiert. | bearbeitet und analysiert. | Other |
Send an Enquiry
Request a quote, ask about capacity, or discuss your testing requirements directly with this lab.